CopyMark Law Group
4.9
Drawing for SLISUR

USPTO serial 79357946

SLISUR

Reviewed by CopyMark Law Group

Reg. 7435304Status 700Registered
Filing date
Status date
Registration date
Jul 9, 2024
Examiner
REINHART, MEGHAN M
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SLISUR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical and biological substances in the nature of oligo- and poly-nucleotide arrays for scientific and medical research; reagents for scientific purposes; chemical and biological solvents for DNA and RNA extraction other than for medical or veterinary use; reagents for research in the field of diagnostics; chemical and biological substances in the nature of chemical and biological solvents for DNA and RNA extraction other than for medical or veterinary use; reagents for scientific or medical research use and reagents for scientific and research useACTIVE—
005Medical and veterinary preparations for the treatment of cancer and infectious diseases; Pharmaceuticals, namely vaccines; chemical and biological substances in the nature of oligo- and poly-nucleotides andnucleotides for medical and veterinary treatment purposes and apatamers in the nature of nucleic acid antibodiesfor medical and veterinary purposes; reagents as part of medical and veterinary preparations; chemical and biological substances in the nature of oligo- and poly-nucleotides and nucleic acid antibodies all for medical and veterinary use; reagents for medical and veterinary use; agonists for medical and veterinary use; TLR agonists for medical and veterinary use; agonists as part of medical and veterinary preparations; TLR agonists as part of medical and veterinary preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 23, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 25, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 14, 2024XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Dec 14, 2024XXCRGENERIC MADRID TRANSACTION CREATED—
Oct 9, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 9, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 9, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 21, 2024CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jun 17, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 14, 2024CHLDCHANGE OF OWNER RECEIVED FROM IB—
May 15, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 15, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 23, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 23, 2024GPNXNOTIFICATION PROCESSED BY IB—
Apr 23, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 3, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 3, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 3, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 21, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 21, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Mar 21, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 21, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 21, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 7, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 7, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 7, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 10, 2023RFNTREFUSAL PROCESSED BY IB—
Sep 20, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 20, 2023RFRRREFUSAL PROCESSED BY MPU—
Sep 1, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 31, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 22, 2023DOCKASSIGNED TO EXAMINER—
Dec 23, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 19, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 17, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance